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Abstract: Recombination is an important process that influences biological evolution at 
many  different  levels.  More  and  more  homologous  recombination  events  have  been 
reported among negative sense RNA viruses recently. While sporadic authentic examples 
indicate that homologous recombination does occur, recombination seems to be generally 
rare or even absent in most negative sense RNA viruses, and most of the homologous 
recombination events reported in the literature were likely generated artificially due to lab 
contamination  or  inappropriate  bioinformatics  methods.  Homologous  recombination  in 
negative sense RNA viruses should be reported with caution in the future, and only after 
stringent quality control efforts. Moreover, co-infection experiments should be performed 
to confirm whether recombination can occur. 
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1. Introduction 
Negative  sense  RNA  viruses  (NSVs)  differ  widely  in  morphology  and  host  interactions.  NSVs 
include a myriad of important pathogens such as influenza viruses, measles virus (MeV), Newcastle 
disease virus (NDV), rinderpest virus (RPV) and many others infecting humans, several wild  and 
domesticated animals, and plants. NSVs have varied genome structures and are classified into seven 
families,  Rhabdoviridae, Paramyxoviridae, Filoviridae, Bornaviridae, Orthomyxoviridae, Bunyaviridae, 
and Arenaviridae  [1].  The  first  four  families  are  characterized  by  non-segmented  genomes  and 
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constitute the order Mononegavirales [1]. The latter three families have genomes comprising multiple 
negative sense RNA segments.  
RNA viruses show high mutation frequencies partly because of a lack of the proofreading enzymes 
that  assure  fidelity  of  DNA  replication  [2,3].  While  mutation  is  the  ultimate  source  of  genetic 
variation,  recombination  can  act  on  mutation  to  shape  the  genetic  structure  of  populations.  Two 
distinct mechanisms can generate viral recombinant genomes [4,5]. Reassortment occurs when two or 
more multipartite viruses co-infect a single host cell and exchange discrete RNA segments to form 
genetically  novel  progeny  viruses.  Antigenic  shift  in  influenza  virus,  a  reassortment  event  that 
generates a novel combination of the hemagglutinin (HA) and neuraminidase (NA) antigens, provides 
an important example for this sort of recombination [6]. Recombination, the other process, can be 
defined as the intramolecular exchange of genetic information between two nucleotide sequences [7]. 
In other words, it occurs when one contiguous stretch of RNA is formed as a mosaic from more than 
one ‘parent’. Recombination events can occur between different genes (non-homologous/intergenic 
recombination) or between alleles of the same gene (homologous/intragenic recombination), although 
new terminologies have been proposed [8,9]. In this review, we focus on homologous recombination 
that involves two similar or closely related RNA molecules with extensive sequence homology [8]. 
During  the  past  two  decades,  many  recombination  analysis  and  detection  methods  have  been 
developed.  These  techniques  differ  greatly  in  approach  and  applicability,  but  may  be  tentatively 
classified into five nonexclusive general categories: Similarity, distance, phylogenetic, compatibility, 
and  nucleotide  substitution  distribution  methods  [5].  A  comprehensive  list  of  these  recombination 
analysis and detection programs can be found in the following website [10]. These methods generally 
focus  on  one  or  more  aspects  of  recombination,  including  estimating  the  recombination  rate, 
identifying parental and recombinant sequences, and mapping recombination breakpoints. Different 
recombination analysis and detection methods show distinct performance and the relative performance 
has  been  evaluated  by  both  theoretical  and  empirical  studies,  leading  to  the  suggestion  that  
definitive conclusions about the presence of recombination should not be derived on the basis of a 
single method [7,11].  
2. False Positive Recombination Signals 
False positive recombination signals can be generated artificially. The most important alternative 
hypothesis for putative recombination is laboratory contamination. If samples from co-infected hosts 
contain RNA genomes present from multiple viruses, subsequent PCR amplification, especially with 
primers  from  different  regions,  may  result  in  specific  segment  sub-regions  being  amplified  from 
different viruses, then concatenated in silico, giving the appearance of recombination where none has 
occurred [12]. Errors can also occur during data processing. Zhang and Liu recently reported a single 
recombination  event  between  mumps virus  (MuV)  wild  type  Drag94  and  the  vaccine  strain 
L3/Russia/Vector, leading to a putative recombinant 9218/Zg98 strain, after analyzing 30 complete 
viral genomes retrieved from GenBank [13]. The sequence of strain 9218/Zg98 is 100% identical to 
strain  L3/Russia/Vector  in  the  recombination  region.  Both  strains  were  sequenced  in  the  same 
laboratory.  Subsequently,  the  sequence  submitter  discovered  that  there  was  an  error  during  the 
submission process [14–16]. Viruses 2011, 3                         
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Template jumping between different templates during PCR amplification can also result in apparent 
recombination. Some researchers argue that recombinants only represent a minor portion of the PCR 
amplicon and the resulting sequence is a consensus sequence of the overall population of amplicons 
and thus exclude this possibility of recombination [17]. However, previous studies have indicated that, 
for example, ~5% of the 16S sequences within curated collections are anomalous or suspect, with 
chimeras accounting for the majority of problematic sequences [18]. PCR amplification with samples 
infected with genetically diverse Plasmodium parasites generated ample in vitro recombinants [19]. 
This observation indicates that recombinant sequences generated by sequencing PCR products are not 
rare, and there is no reason to suspect that RNA viruses would be immune to similar pitfalls. 
Bioinformatic methods can be another source of artifacts that look deceptively similar to genuine 
recombination. All recombination methods can infer false positives, albeit often at low levels [7]. For 
instance, lineage-specific rate variation can result in false positive recombination signals. An important 
example lies in the 1918 Spanish flu virus. Homologous recombination was proposed to occur in the 
HA gene of the 1918 Spanish flu virus [20]. However, this apparent recombination event was later 
shown to be the result of differences in the substitution rate between HA1 and HA2 [21]. Because the 
HA1 domain evolves so much faster than the HA2 domain in human (but not swine) influenza A 
viruses, the 1918 strain appears to be closer to classical swine influenza strains than to recent human 
strains, based on approaches that rely primarily on sequence similarity. In such cases, a phylogenetic 
approach that can infer shared ancestry, even when some lineages evolve relatively slowly or rapidly, 
is  key.  This  problem  goes  beyond  RNA  viruses  and  was  encountered,  for  instance,  when  crude 
methods  based  on  sequence  similarity,  rather  than  phylogenetic  relatedness,  led  to  erroneous 
conclusions of lateral gene transfer from bacteria to vertebrates including humans [22]. 
3. Guidelines for Identifying Recombination 
Boni et al. recently proposed guidelines for identifying homologous recombination in influenza A 
virus  [12].  Following  their  lead,  here  we  propose  a  set  of  relatively  simple  guidelines  and 
recommendations for identifying recombination in NSVs, which we believe can also be applied to 
other kinds of viruses. These guidelines and recommendations are not foolproof and are not meant to 
replace healthy skepticism of results suggestive of recombination in RNA viruses. The key point is that 
researchers must explain to themselves, to reviewers, and to others why sequences should be believed 
to be authentic recombinants rather than ignoring the very real possibility of artifacts of one sort or 
the other. 
3.1. Excluding the Possibility of Laboratory Contamination 
Apparently mosaic sequences should be reproducible. If possible, sequences should be generated 
after  plaque  purification  or  limiting  dilution,  and  multiple  independent  extractions  followed  by 
amplification and sequencing should be performed. Single-genome amplification (SGA), which has 
been  used  extensively  to  characterize  the  genetic  identity  and  complexity  of  human  and  simian 
immunodeficiency viruses [23–27], is highly recommended.  
Evidence that recombinant sequences form a distinct circulating lineage, with readily identifiable 
parents, and have been transmitted among multiple individuals in a population, are strong indicators of Viruses 2011, 3                         
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authentic recombination events.  If one or more of the putative parental strains are ones that have 
commonly been used in the laboratory, or if recombination break points lie near primer loci, checking 
the  authenticity  of  sequences  by  repeating  extractions  and  sequencing  assays  becomes 
particularly important. 
3.2. Excluding the Possibility of False Positive Signals Due to Bioinformatics Errors 
Definitive conclusions about the presence of recombination should not be derived on the basis of a 
single  method  [7].  Phylogenetic  analysis  provides  a  robust,  informative,  and  necessary  test  of  the 
recombination hypothesis. The gold-standard bioinformatics approach for demonstrating the presence 
of recombination is a set of statistically incongruent phylogenetic trees for different genomic regions 
[12]. Given the intrinsic uncertainty in solving phylogenetic relationships, statistical procedures, such 
as the Shimodaira-Hasegawa test [28], are highly recommended for performing topology testing of 
phylogenies. 
Alignment errors or uncertainty can also lead to false positive recombination signals [12], due to 
either  similarity  shifts  or  phylogenetic  discrepancies  caused  by  misaligned  sequences.  Therefore, 
sequence alignments should be visually analyzed for obvious alignment errors before carrying out 
recombination analysis [12]. 
4. Recombination Events in Negative Sense RNA Viruses 
Frequent  generation  of  defective  interfering  (DI)  RNA,  which  can  be  viewed  as  one  form  of  
non-homologous recombination has been observed in NSVs [29]. However, extensive co-infection 
experiments  performed  many  years  ago,  with  a  variety  of  markers,  failed  to  reveal  evidence  of 
homologous recombination in Newcastle disease virus (NDV) and vesicular stomatitis virus (VSV), 
suggesting that recombination is either very rare or nonexistent in some NSVs [2,30]. Decades later, 
two  studies  showed  unambiguously  that  recombination  can  occur  in  both  non-segmented  and 
segmented NSVs [31,32]. Transfection-mediated homologous recombination in vitro resulted in the 
rescue of functionally competent Tula hantavirus with a recombinant S RNA segment [31]. And mixed 
infection in vitro by human respiratory syncytial virus (RSV) yielded a viable, helper-independent 
mononegavirus  [32].  However,  the  isolation  of  only  a  single  recombinant  RSV  under  optimized 
conditions suggests that recombination is rare indeed in RSV [32]. Systematic phylogenetic analyses 
have suggested a low rate of recombination in negative sense RNA viruses [33]. However, with the 
increasing availability of viral sequences, more and more recombination events have been reported in 
NSVs recently. Table 1 provides what is to our knowledge the complete list of recombination events 
reported in NSVs to date, which is discussed in turn below. Until now, homologous recombination is 
reported only in animal-infecting NSVs and, to our knowledge, there is no report on recombination in 
plant-infecting NSVs. 
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Table 1. List of reported recombination in negative sense RNA viruses. 
Virus  Type  Family  Evidence  Reference 
Arenavirus  Segmented  Arenaviridae  Sequence  [34–38] 
Crimean-Congo hemorrhagic fever virus  Segmented  Bunyaviridae  Sequence  [39,40] 
Hantaviruses  Segmented  Bunyaviridae  Sequence/Transfection  [31,41–47] 
Zaire ebolavirus  Nonsegmented  Filoviridae  Sequence  [48] 
Infectious salmon anemia virus  Segmented  Orthomyxoviridae  Sequence  [49,50] 
Influenza A virus  Segmented  Orthomyxoviridae  Sequence/Coinfection  [20,51–55] 
Canine distemper virus  Nonsegmented  Paramyxoviridae  Sequence  [56,57] 
Respiratory syncytial virus  Nonsegmented  Paramyxoviridae  Sequence/Coinfection  [32,58] 
Measles virus   Nonsegmented  Paramyxoviridae  Sequence  [59] 
Mumps virus  Nonsegmented  Paramyxoviridae  Sequence  [13,33] 
Human parainfluenza virus  Nonsegmented  Paramyxoviridae  Sequence  [60] 
Newcastle disease virus  Nonsegmented  Paramyxoviridae  Sequence  [33,61–67] 
Rabies virus  Nonsegmented  Rhabdoviridae  Sequence  [68] 
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4.1. Influenza Virus 
Influenza viruses undergo various forms of non-homologous recombination, albeit rarely [69–71]. 
However,  homologous  recombination  is  hotly  debated  in  influenza  viruses.  Homologous 
recombination  was  proposed  to  occur  in  the  HA  gene  of  the  1918  Spanish  flu  virus  [20].  This 
intragenic recombination was speculated to have resulted in the increased virulence associated with the 
Spanish flu pandemic. As described above, this apparent recombination event was actually an artifact 
of differences in the substitution rate between the HA1 and HA2 regions [21]. Recently, homologous 
recombination  is  suggested  to  take  place  between  influenza  virus  strains  sharing  high  sequence 
similarity [54]. However, the p-values obtained from standard recombination detection algorithms are 
ambiguous, making the claims unconvincing.  
Several recent studies have reported new evidence for recombination in avian, human, and swine 
influenza A virus lineages [51–54]. For example, a clade of three circulating H9N2 avian influenza 
viruses with similar mosaic PA genes descended from H9N2 and H5N1 was reported and showed that 
recombination may have occurred. Further back in time, one experimental study that has been largely 
overlooked revealed that, following mixed infection of two viral strains, one reassortant contained a 
nucleoprotein  (NP)  segment  with  sequences  derived  from  each  parental  virus  as  a  result  of  a 
recombination event [55]. 
These findings, however, must be viewed in the context of recent large-scale analyses of influenza 
A, B, and C viruses that showed that recombination is exceedingly rare. Most recombination reported 
in the literature [51–54] has involved sequences retrieved from public databases such as GenBank. 
However, typically in such cases sample handling and amplification and sequencing approaches are of 
unknown  quality  and  some  putative  recombinants  were  isolated  decades  apart  from  their  parental 
sequences, which make the recombinant sequences highly suspect, to say the least [12]. An analysis of 
8307 publicly available full-length sequences of influenza A segments indicated that sequences from 
the National Institutes of Health Influenza Genome Sequencing Project (IGSP), which were generated 
under stricter quality control procedures than other published influenza virus sequences, included only 
two phylogenetically supported single recombinant sequences and no recombinant clades that would 
be indicative of circulating recombinant forms. The non-IGSP data, on the other hand, showed a much 
larger amount of potential recombination [12]. Because sample handling and sequencing are executed 
to  a  very  high  standard  in  the  IGSP  these  sequences  should  be  less  likely  to  be  exposed  to 
contamination  by  other  samples  or  laboratory  strains,  and  thus  should  be  less  likely  to  exhibit 
laboratory-generated  signals  of  homologous  recombination.  Conversely,  the  higher  frequency  of 
putative recombinants in less stringently generated influenza virus sequences is likely due to artifacts. 
Additional unpublished results have confirmed that influenza virus recombinant sequences are often 
generated  artificially.  The  NP  gene  sequences  of  A/chicken/Shantou/5738/2001(H5N1)  (GenBank 
accession No. CY029091) and A/chicken/Shantou/28/2002(H5N1) (GenBank accession No. CY029112) 
initially showed strong homologous recombination signals. However, when the two NP genes were  
re-sequenced from original virus stocks, each new sequence differed in the first 500–600 bp from the 
ones  in  GenBank  [72]  and  the  apparent  recombination  was  revealed  to  be  due  to  laboratory 
contamination and/or sequencing errors (both published sequences have now been replaced by the Viruses 2011, 3                         
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corrected ones). Hence, sequences in public repositories, though valuable for exploratory purposes, are 
not generally sufficient for producing definitive conclusions of recombination in influenza viruses. 
Given  the  evidence  to  date,  homologous  recombination  seems  to  play  little  or  no  role  in  the 
evolution of influenza viruses in natural settings. 
4.2. Ebola Virus  
One potentially interesting  example of recombination in NSVs is a lineage of  Zaire ebolavirus 
reported to have a hybrid origin [48]. Zaire ebolavirus is one of the most virulent human pathogens, 
causing acute hemorrhagic fever that can lead to death in a matter of days, with a very high fatality 
rate. The putative recombination event was inferred to have occurred between 1996 and 2001 giving 
rise to a group of recombinant viruses that were responsible for a series of outbreaks in 2001–2003 
[48].  However,  this  evidence  was  only  based  on  phylogenetic  analyses  of  two  distinct  genes, 
glycoprotein (GP) and NP. The detection of at least nine genetically distinct lineages of Marburg virus 
that belong to the genus of ebolavirus in circulation during the outbreak of Marburg hemorrhagic fever 
most intensively in 1999 suggests that co-infection with multiple filovirus strains is a possibility [73]. 
If samples contain multiple virus strains, PCR amplification of distinct genomic regions can lead to 
different  strains  being  sequenced  for  different  genomic  regions  and  the  generation  of  a  group  of 
artificial recombinant sequences is possible. Therefore, additional experiments would be necessary to 
confirm this recombination event, preferably by pinpointing the actual recombination breakpoint(s) 
within a single amplicon. 
4.3. Newcastle Disease Virus  
Between the 1950s and 1960s, extensive co-infection experiments with NDV using a variety of 
markers failed to reveal any evidence of recombination [30]. These experiments led to the conclusion 
that  recombination  might  not  be  a  feature  of  the  biology  of  NDV.  With  the  advent  of  modern 
molecular biology techniques, however, many NDV gene or genome sequences have become available 
and  many  recombination  events  have  been  reported  [33,61–67].  Laboratory  contamination  is  of 
particular concern here because vaccine derived strains contributed the majority of the recombinant 
regions, and these strains might well have been present in laboratories sequencing field strains of 
NDV. Chong et al. argued that the presence of unique nucleotide substitutions in the recombinant 
regions compared to the comparable region of the predicted parental genotypes suggests that these 
regions did not arise due to contamination with vaccine strains deposited in the sequence databases 
[65].  However,  the  widespread  use  of  live  vaccines  in  poultry  and  the  extensive  presence  of  
non-virulent endemic NDVs in live bird markets and in wild animals make the existence of unnoticed 
mixed infections in field samples a strong possibility [74]. 
With frequent mixed infections of NDV (in 5–15% of wildlife isolates and perhaps much higher 
levels in vaccinated poultry) there is a high likelihood of having two or more viruses in the same 
inoculum during egg-amplification during initial isolation. Although plaque purification steps were 
performed in some of these studies, no attempts were made to confirm the absence of contaminating 
viruses in the original samples or to investigate the possibility of contamination with PCR products, Viruses 2011, 3                         
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which normally abound in NDV sequencing laboratories [75]. Some of the apparent recombinants 
available in GenBank have now been confirmed to be artificially generated ones [76,77]. 
However,  several  viruses  isolated  from  1971  through  2006  in  North  America  share  a  virtually 
identical breakpoint. Because most of these viruses were isolated independently at different time points 
and/or locations, this event appears to have occurred naturally and not as the result of a laboratory 
artifact  [67].  The  details  of  these  recombinants  should  be  further  investigated  in  the  future.  
More importantly, whole genome sequencing following co-infection experiments, possibly between 
wild-type and vaccine strains, would be useful for determining experimentally whether recombination 
can indeed occur in NDV and how frequent it may be. 
4.4. Hantavirus  
To date, the strongest evidence for recombination in NSVs comes from hantaviruses. Hantaviruses 
constitute a genus in the Bunyaviridae family. Phylogenetic analysis of the S segment indicated that 
the  eastern  Slovakian  Tula  hantavirus  underwent  homologous  recombination  and  formed  an 
independent lineage [41]. A later transfection-mediated rescue of Tula virus generated a recombinant S 
RNA  segment  and  independent  attempts  yielded  S  RNA  molecules  of  similar  structure  with  a 
breakpoint located close to one of the breakpoints suggested for the natural recombinants [31]. The 
possibility of the occurrence of such similar breakpoints seems exceedingly low. Thereafter, several 
reports  of  recombination  in  members  of  the  hantavirus  genus  followed,  including  Hantaan  virus, 
Dobrava virus, Andes virus, and Puumala virus [42–47]. Therefore, recombination appears to be a 
common occurrence in hantaviruses, relative to most other NSVs. This suggests there are unknown 
mechanisms contributing to hantavirus recombination that might be interesting in their own right and 
also potentially informative about why other NSVs do not appear to undergo much recombination. 
4.5. Arenavirus 
Phylogenetic analyses based on the viral glycoprotein precursor (GPC) and the nucleoprotein (NP) 
encoded by the S RNA segment suggest a common hybrid origin of Catarina virus, Skinner Tank 
virus, Whitewater arroyo virus, Tamiami virus, and Bear canyon virus, defined as the A/Rec lineage 
[34–38]. However, an alternative explanation based on the peculiarity of the GP1 region within the 
GPC gene has been proposed [37]. GP1 is highly variable in clades B and the A/Rec lineage and the 
problematic  alignment  of  the  GP1  regions  represents  a  potentially  confounding  factor  for  these 
phylogenetic analyses [37]. Nevertheless, when only the most conserved regions of GPC are used, the 
inconsistency of relationships between North American arenaviruses and clades A and B arenaviruses 
is still present [37,38]. We believe is it plausible that, like the spurious signal of recombination in the 
1918 Spanish Influenza hemagglutinin gene, the phylogenetic information derived from the arenavirus 
GPC  is  influenced  by  specific  selection  pressures  [36].  Given  the  phenomenon  of  superinfection 
exclusion and the absence of any lab-created or characterized arenavirus recombinants, the possibility 
of  recombination  in  arenaviruses  remains  unsubstantiated  [37,78–80].  Therefore,  more  studies  are 
needed to attempt to distinguish phylogenetic signals generated by recombination and selection.  Viruses 2011, 3                         
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4.6. Summary 
Most of the reported cases of recombination in NSVs appear to be artifacts upon closer scrutiny. 
While recombination clearly does occur in some NSVs, such as hantaviruses and RSV, homologous 
recombination is evidently generally rare in NSVs. 
5. Constraints on Recombination in Negative Sense RNA Viruses 
Why  is  the  recombination  rate  so  low  in  negative  sense  RNA  viruses?  While  it  is  difficult  to 
provide a definitive answer to this crucial question, several factors may contribute to it. The viral RNA 
of  NSVs  is  condensed  by  the  nucleoprotein  into  a  helical  nucleocapsid,  which  is  called 
ribonucleoprotein  complex  (RNP)  and  which  serves  as  a  suitable  template  for  replication.  Unlike 
cores, capsids, or nucleocapsids of positive-strand RNA viruses or DNA viruses, RNPs apparently 
never disassemble, and RNA synthesis does not change the structure of the RNA-N protein template 
[81–84]. The RNP may thus be a barrier to RNA recombination. On the other hand, the production of 
defective  interfering  (DI)  RNAs  indicates  that  the  polymerase  is  able  to  jump  off  and  on  to  the 
template of RNA molecules relatively frequently [29].  
Recombination is generated by the  exchange of genetic material between viruses that  co-infect 
individual host cells. Therefore, a low rate of co-infection will result in a low rate of recombination. 
Several  factors  could  limit  virus  co-infection.  For  example,  negative-sense  RNA  viruses  tend  to 
produce acute infections with relatively short recovery periods. While recombination in hantaviruses 
seems to be the best evidence yet observed, it is worth noting that hantaviruses can establish persistent 
infections in their rodent hosts [41,46]. Superinfection exclusion, in which a primary viral infection 
prevents  a  secondary  infection with  the  same  or  closely  related  virus,  is  another  potentially 
recombination-limiting feature that has been observed in several negative sense viruses, such as Borna 
disease virus, measles virus, and vesicular stomatitis virus [85,86].  
Another possible reason for a low level of observed recombinants is the potentially low fitness of 
recombinants, which will be selected against. The recombinant Tula hantavirus has been observed to 
be  less  competitive  than  the  wild  type  [31,87], though  why  NSV  recombinants  should  be  less  fit 
generally than recombinants in other viral lineages is not clear.  
6. Implications  
Viral  sequences  have  been  widely  used  for  phylogenetic  analyses  to  decipher  the  evolutionary 
dynamics,  determine  the  genotypes,  and  trace  the  spread  of  viruses.  However,  both  natural  and 
artificial  recombination  are  routinely  ignored  in  most  of  these  phylogenetic  analyses.  Ignoring 
recombination might severely compromise phylogenetic analyses, because different genomic regions 
will have different evolutionary histories [88]. We suggest that recombination detection should be a 
standard component of every phylogenetic analysis of negative sense RNA viruses. Even though the 
evidence  to  date  suggests  recombination  may  be  rare,  such  analyses  also  serve  an  important  
quality-control function by helping to weed out laboratory and analytical errors. 
There are also practical implications of recombination in NSVs. For instance, NDV has recently 
been proposed as a potential vector in the development of a novel bi- or multivalent vaccine [89–91]. Viruses 2011, 3                         
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The sporadic reports on recombination in non-segmented negative sense RNA viruses have led to 
cautions about safety issues with respect to the use of NDV-based live attenuated vaccines [92]. This 
issue is under intense debate at the moment [75,92–94]. Although the evidence for recombination is 
not overwhelming to date [75], recombination cannot be excluded, especially due to the discovery of a 
lineage with virtually identical breakpoint [67]. Recombination between a vaccine virus and other 
circulating non-segmented negative-strand RNA viruses resulting in unexpected recombinants and the 
potential instability of the inserted foreign gene should be fully addressed and evaluated. 
7. Conclusions and Further Directions 
Sporadic  authentic  examples  suggest  that  homologous  recombination  does  occur  in  NSVs. 
However, homologous recombination seems to be very rare or even absent in most NSVs. Most of the 
recombination  events  reported  in  the  literature  appear  to  have  been  generated  artificially  due  to 
laboratory  contamination  or  unsuitable  bioinformatics  methods.  Therefore,  putative  homologous 
recombination events in NSVs should be treated with caution. Providing detailed explanations of why 
possible cases should be believed to be authentic recombination should be standard practice when 
reporting  recombination  in  NSVs.  Similarly,  co-infection  experiments  should  be  performed  to 
determine experimentally whether homologous recombination occurs in NSVs and at what rate NSVs 
recombine, if at all. If no recombination is observed in the most permissive laboratory settings with a 
particular virus, this is all the more reason to treat apparent cases of natural recombination in wild 
viruses of the same type with suitable skepticism. 
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